SCHEMBL21137346

SCHEMBL21137346

COc1cccc(F)c1-c1c(Cl)cc2c(N3CCNCC3)c(OC)cnc2c1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 3/20 0.45
NTRK1 P04629 1/20 0.44
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ACVR1B P36896 1/20 0.41
TGFBR1 P36897 1/20 0.41
ACVR1 Q04771 1/20 0.41
KCNH2 Q12809 1/20 0.41
HTR7 P34969 2/20 0.40
HTR1A P08908 1/20 0.40
KRAS P01116 1/20 0.40
BCL6 P41182 1/20 0.40
SLC6A3 Q01959 1/20 0.38
HTR6 P50406 3/20 0.38
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
CHEK2 O96017 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136787 0.82 KRAS (0.44) MAP4K1KRASMAPT
Hydrochloric Acid SCHEMBL16637286 0.81 NTRK1 (0.45) MAP4K1NTRK1TGFBR1ACVR1KRAS
SCHEMBL21099627 0.80 KRAS (0.55) MAP4K1NTRK1KRASCHEK2
SCHEMBL16636995 0.76 KRAS (0.53) MAP4K1NTRK1CYP3A4CYP2C19HTR7
SCHEMBL21137320 0.74 KRAS (0.43) MAP4K1KRASMAPT
SCHEMBL18153560 0.73 NTRK1 (0.41) MAP4K1NTRK1KCNH2HTR7HTR1A
SCHEMBL21099397 0.71 KRAS (0.43) MAP4K1NTRK1KRAS
SCHEMBL21136812 0.71 KRAS (0.59) KRAS
SCHEMBL21050778 0.71 KRAS (0.69) KRAS
SCHEMBL18128443 0.70 NTRK1 (0.40) MAP4K1NTRK1CYP3A4HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed